
Hoxirab IT 20mg/150mg Capsule SR
Marketer
Biochemix Health Care Pvt. Ltd.
Salt Composition
Rabeprazole (20mg) + Itopride (150mg)
Overview Hoxirab IT 20mg/150mg Capsule SR
Gastroesophageal reflux disease (GERD) and peptic ulcer disease are effectively managed with the dual-action formulation, Hoxirab IT 20mg/150mg sustained-release capsules. This medication alleviates common acidity symptoms like heartburn, stomach upset, and irritation by neutralizing stomach acid and facilitating gas expulsion. Dosage and treatment duration for Hoxirab IT 20mg/150mg SR capsules should strictly follow your physician's instructions, varying based on individual response and condition severity. Premature discontinuation may lead to symptom recurrence and disease exacerbation. Complete disclosure of all other medications to your healthcare provider is crucial, as potential interactions exist. While generally well-tolerated, common side effects include abdominal pain, altered bowel habits (diarrhea or constipation), headache, gas, fatigue, and increased salivation. These are usually transient. Report any concerning side effects immediately to your doctor. Due to potential drowsiness and dizziness, avoid activities requiring alertness, such as driving, until the medication's effects are known. Alcohol consumption should be avoided as it may intensify sleepiness. Lifestyle adjustments, such as consuming cool milk and abstaining from hot beverages, spicy foods, and chocolate, can enhance treatment outcomes. Prior to commencing therapy, inform your doctor of any pre-existing liver conditions, pregnancy, pregnancy plans, or breastfeeding.
Primary Ingredients of Hoxirab IT 20mg/150mg Capsule SR
No text provided. Please provide the text you would like me to rephrase.
Uses of Hoxirab IT 20mg/150mg Capsule SR
Stomach acid disorders encompassing reflux and ulcers.
Major Benefits of Hoxirab IT 20mg/150mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire capsule without chewing, crushing, or breaking it. Administer Hoxirab IT 20mg/150mg Extended-Release Capsules on an empty stomach.
Common Side effects of Hoxirab IT 20mg/150mg Capsule SR:
- Stomach pain
- Diarrhea
- Constipation
- Headache
- Dizziness
- Flatulence
- Weakness
- Flu-like symptoms
- Increased saliva production
How to use Hoxirab IT 20mg/150mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Hoxirab IT 20mg/150mg SR Capsules. These capsules should be swallowed whole; do not chew, crush, or break them. Administer on an empty stomach.
How Hoxirab IT 20mg/150mg Capsule SR works:
Hoxirab IT 20mg/150mg sustained-release capsules contain rabeprazole and itopride, acting synergistically to alleviate acid-related digestive issues. Rabeprazole, a proton pump inhibitor (PPI), lowers stomach acid production, providing relief from heartburn and indigestion. Itopride, a prokinetic agent, influences the brain's vomiting center and enhances gastrointestinal motility, facilitating smoother food passage through the digestive system.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Hoxirab IT 20mg/150mg SR Capsules concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Hoxirab IT 20mg/150mg SR Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers before prescribing this medication. Seek medical advice from your doctor.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Hoxirab IT 20mg/150mg sustained-release capsules while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Hoxirab IT 20mg/150mg sustained-release capsules could reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Hoxirab IT 20mg/150mg SR capsules in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Hoxirab IT 20mg/150mg sustained-release capsules. Dosage modification of Hoxirab IT 20mg/150mg sustained-release capsules may be necessary. Physician consultation is advised.
What if you forget to take Hoxirab IT 20mg/150mg Capsule SR :
Should you forget a dose of Hoxirab IT 20mg/150mg SR Capsule, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Hoxirab IT 20mg/150mg Capsule SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Gastrointestinal system |
